Shot in the arm

9 Feb 2022 By John Foley

The U.S. health retailer made around $4 bln in extra revenue from providing vaccines and tests in 2021, earning about 10 times its usual profit margin. Most of the gain will pay for a higher dividend. That’s the cost of getting the private sector to deliver a public good.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)